Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The seeding medium consisted of DMEM (Gibco, #31966-021) supplemented with 10% v/v FBS (Gibco, #16140-071), 1% v/v Penicillin-Streptomycin (Gibco, #15140-122)
(Cambridge, MA: Academic Press), 183199
Similar to the acute phase of C-19, L-C19 also depends on a series of risk factors such as sex, age, co-morbidities, severity of C-19, hospitalization and its duration, C-19 sequelae, the treatment applied in the acute phase, vaccination, as well as lifestyle
Nausea is the most common, with most patients reporting peak symptoms in week 1 to 2 of each new dose step
US$ 22.04
/assets/images/provider/photos/2775922.jpeg)
US$ 20.95
US$ 25.55
US$ 20.58
